ATE366809T1 - Addressine der schleimhaut und der blutgefässe und ihre verwendung - Google Patents
Addressine der schleimhaut und der blutgefässe und ihre verwendungInfo
- Publication number
- ATE366809T1 ATE366809T1 AT96906504T AT96906504T ATE366809T1 AT E366809 T1 ATE366809 T1 AT E366809T1 AT 96906504 T AT96906504 T AT 96906504T AT 96906504 T AT96906504 T AT 96906504T AT E366809 T1 ATE366809 T1 AT E366809T1
- Authority
- AT
- Austria
- Prior art keywords
- madcam
- primate
- recombinant
- proteins
- relates
- Prior art date
Links
- 210000004204 blood vessel Anatomy 0.000 title 1
- 210000004877 mucosa Anatomy 0.000 title 1
- 241000288906 Primates Species 0.000 abstract 5
- 102000039446 nucleic acids Human genes 0.000 abstract 4
- 108020004707 nucleic acids Proteins 0.000 abstract 4
- 150000007523 nucleic acids Chemical class 0.000 abstract 4
- 210000000265 leukocyte Anatomy 0.000 abstract 3
- 210000004027 cell Anatomy 0.000 abstract 2
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 abstract 1
- 108091005461 Nucleic proteins Proteins 0.000 abstract 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000003038 endothelium Anatomy 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000007115 recruitment Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/386,857 US6551593B1 (en) | 1995-02-10 | 1995-02-10 | Treatment of Inflammatory bowel disease by inhibiting binding and/or signalling through α 4 β 7 and its ligands and madcam |
| US08/523,004 US7750137B2 (en) | 1995-09-01 | 1995-09-01 | Mucosal vascular addressins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE366809T1 true ATE366809T1 (de) | 2007-08-15 |
Family
ID=27011628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96906504T ATE366809T1 (de) | 1995-02-10 | 1996-02-12 | Addressine der schleimhaut und der blutgefässe und ihre verwendung |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0808367B1 (de) |
| JP (1) | JP4205162B2 (de) |
| AT (1) | ATE366809T1 (de) |
| AU (1) | AU4986296A (de) |
| CA (1) | CA2212702C (de) |
| DE (1) | DE69637155T2 (de) |
| DK (1) | DK0808367T3 (de) |
| ES (1) | ES2290955T3 (de) |
| MX (1) | MX9706049A (de) |
| NZ (1) | NZ303523A (de) |
| PT (1) | PT808367E (de) |
| WO (1) | WO1996024673A1 (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001503271A (ja) * | 1996-11-01 | 2001-03-13 | ヒューマン ジノーム サイエンシーズ，インコーポレイテッド | ヒト粘膜アドレシン細胞接着分子―１（ＭＡｄＣＡＭ―１）およびそのスプライス変異体 |
| WO1998051345A2 (en) * | 1997-05-09 | 1998-11-19 | The John P. Robarts Research Institute | Method for dislodging infiltrated leukocytes from a tissue |
| US7090845B2 (en) | 1998-05-13 | 2006-08-15 | Genentech, Inc. | Diagnosis and treatment of hepatic disorders |
| DK1078006T3 (da) * | 1998-05-13 | 2009-06-02 | Genentech Inc | Diagnose og behandling af leverlidelser |
| AU2007201698B2 (en) * | 1998-05-13 | 2011-10-13 | Genentech, Inc. | Diagnosis and treatment of hepatic disorders |
| AUPR524101A0 (en) | 2001-05-25 | 2001-06-21 | Council Of The Queensland Institute Of Medical Research, The | Antigen targeting |
| WO2003047526A2 (en) * | 2001-11-30 | 2003-06-12 | Incyte Genomics, Inc. | Cell adhesion and extracellular matrix proteins |
| US20070202097A1 (en) * | 2003-03-10 | 2007-08-30 | Krissansen Geoffrey W | Monoclonal Antibodies That Recognise Mucosal Addressin Cell Adhesion Molecule-1 (Madcam-1), Soluble Madcam-1 And Uses Thereof |
| ATE491718T1 (de) * | 2003-05-01 | 2011-01-15 | Scripps Research Inst | Selektive r-cadherin-antagonisten und verfahren |
| PT2177537E (pt) * | 2004-01-09 | 2011-12-13 | Pfizer | Anticorpos contra madcam |
| DK2322556T3 (en) * | 2004-09-03 | 2016-01-25 | Genentech Inc | Humanized anti-beta7 antagonists, and uses thereof |
| WO2007007173A2 (en) | 2005-07-08 | 2007-01-18 | Pfizer Limited | Human anti-madcam antibodies |
| WO2007007152A2 (en) * | 2005-07-11 | 2007-01-18 | Pfizer Limited | Anti-madcam antibodies to treat metastatic cancers and chloroma |
| WO2009140684A2 (en) * | 2008-05-16 | 2009-11-19 | Genentech, Inc. | Use of biomarkers for assessing treatment of gastrointestinal inflammatory disorders with beta7integrin antagonists |
| UA116189C2 (uk) | 2011-05-02 | 2018-02-26 | Мілленніум Фармасьютікалз, Інк. | КОМПОЗИЦІЯ АНТИ-α4β7 АНТИТІЛА |
| KR102014512B1 (ko) | 2011-05-02 | 2019-08-26 | 밀레니엄 파머슈티컬스 인코퍼레이티드 | 항-α4β7 항체에 대한 제형 |
| WO2016086147A1 (en) | 2014-11-26 | 2016-06-02 | Millennium Pharmaceuticals, Inc. | Vedolizumab for the treatment of fistulizing crohn's disease |
| US20170360926A1 (en) | 2014-12-24 | 2017-12-21 | Millennium Pharmaceuticals, Inc. | PREDICTING OUTCOME OF TREATMENT WITH AN ANTI-alpha4beta7 INTEGRIN ANTIBODY |
| MA41636A (fr) | 2015-03-06 | 2018-01-09 | Millennium Pharm Inc | Méthode de traitement de la cholangite sclérosante primitive |
| US20200002422A1 (en) | 2016-03-14 | 2020-01-02 | Millennium Pharmaceuticals, Inc. | Method of preventing graft versus host disease |
| MX2018011025A (es) | 2016-03-14 | 2019-01-10 | Millennium Pharm Inc | Metodos para tratar o prevenir la enfermedad del injerto contra huésped. |
| TW201735949A (zh) | 2016-03-24 | 2017-10-16 | 千禧製藥公司 | 治療抗ctla4及抗pd-1組合治療中的胃腸道免疫相關不良事件之方法 |
| MA44483A (fr) | 2016-03-24 | 2019-01-30 | Millennium Pharm Inc | Procédés pour traiter des événements indésirables gastro-intestinaux d'origine immunitaire dans des traitements oncologiques immunitaires |
| MA44864A (fr) | 2016-05-04 | 2019-03-13 | Icahn School Med Mount Sinai | Trithérapie pour le traitement d'une maladie intestinale inflammatoire |
| EP3468597A1 (de) | 2016-06-12 | 2019-04-17 | Millennium Pharmaceuticals, Inc. | Verfahren zur behandlung von entzündlicher darmerkrankung |
| WO2018104893A1 (en) | 2016-12-06 | 2018-06-14 | Glaxosmithkline Intellectual Property Development Limited | Alpha4-beta7 antibodies with incrased fcrn binding and/or half-life |
| CA3061320A1 (en) | 2017-04-28 | 2018-11-01 | Millennium Pharmaceuticals, Inc. | Method of treating pediatric disorders |
| BR112020000698A2 (pt) | 2017-07-14 | 2020-07-14 | Pfizer Inc. | anticorpos contra madcam |
| MX2021014178A (es) * | 2019-05-20 | 2022-01-04 | Pandion Operations Inc | Inmunotolerancia dirigida a la molecula de adhesion celular de adresina vascular de mucosas (madcam). |
| TW202504919A (zh) | 2023-05-30 | 2025-02-01 | 美商派拉岡醫療公司 | α4β7整合素抗體組合物及使用方法 |
| WO2024252368A2 (en) | 2023-06-09 | 2024-12-12 | Takeda Pharmaceutical Company Limited | Methods and compositions for treating ulcerative colitis |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994013312A1 (en) * | 1992-12-15 | 1994-06-23 | The Board Of Trustees Of The Leland Stanford Junior University | Mucosal vascular addressin, dna and expression |
-
1996
- 1996-02-12 DK DK96906504T patent/DK0808367T3/da active
- 1996-02-12 AU AU49862/96A patent/AU4986296A/en not_active Abandoned
- 1996-02-12 AT AT96906504T patent/ATE366809T1/de active
- 1996-02-12 JP JP52449196A patent/JP4205162B2/ja not_active Expired - Fee Related
- 1996-02-12 ES ES96906504T patent/ES2290955T3/es not_active Expired - Lifetime
- 1996-02-12 PT PT96906504T patent/PT808367E/pt unknown
- 1996-02-12 NZ NZ303523A patent/NZ303523A/en not_active IP Right Cessation
- 1996-02-12 EP EP96906504A patent/EP0808367B1/de not_active Revoked
- 1996-02-12 DE DE69637155T patent/DE69637155T2/de not_active Expired - Lifetime
- 1996-02-12 WO PCT/US1996/002153 patent/WO1996024673A1/en not_active Ceased
- 1996-02-12 CA CA2212702A patent/CA2212702C/en not_active Expired - Lifetime
- 1996-02-12 MX MX9706049A patent/MX9706049A/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| DE69637155T2 (de) | 2008-02-07 |
| ES2290955T3 (es) | 2008-02-16 |
| CA2212702C (en) | 2010-04-20 |
| DE69637155D1 (de) | 2007-08-23 |
| EP0808367B1 (de) | 2007-07-11 |
| MX9706049A (es) | 1998-02-28 |
| DK0808367T3 (da) | 2007-11-05 |
| NZ303523A (en) | 2002-02-01 |
| JP4205162B2 (ja) | 2009-01-07 |
| PT808367E (pt) | 2007-10-22 |
| AU4986296A (en) | 1996-08-27 |
| WO1996024673A1 (en) | 1996-08-15 |
| CA2212702A1 (en) | 1996-08-15 |
| EP0808367A1 (de) | 1997-11-26 |
| JPH10513365A (ja) | 1998-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE366809T1 (de) | Addressine der schleimhaut und der blutgefässe und ihre verwendung | |
| Geiser et al. | The interleukin-8-related chemotactic cytokines GRO alpha, GRO beta, and GRO gamma activate human neutrophil and basophil leukocytes | |
| ES2063350T5 (es) | Nuevas proteinas con efecto inhibidor del tnf y su obtencion. | |
| Wuyts et al. | Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties | |
| CA2073045C (en) | A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor | |
| DE60219611T2 (de) | Modifizierte annexin-proteine und verhinderung und behandlung von thrombose | |
| KR101151805B1 (ko) | 바이포달 펩타이드 바인더 | |
| US20060173162A1 (en) | Bactericidak anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp) | |
| JP2742925B2 (ja) | 血栓形成抑制用治療薬組成物 | |
| Kokot et al. | Tamm-Horsfall protein updated | |
| WO1996022371A3 (en) | C-C CHEMOKINE RECEPTOR 3: CKP-3 OR Eos-L2 | |
| KR970002917B1 (ko) | 인터루킨-i 억제제 | |
| JPH03204896A (ja) | インターフェロンレセプター細胞外断片 | |
| EP0616615B1 (de) | Analoge des menschlichen Interleukin-8. | |
| KR100237936B1 (ko) | 인터루킨-1 길항제 | |
| EA009414B1 (ru) | Терапевтические применения вариантов хемокинов | |
| Campistol et al. | Polymerization of normal and intact β2-microglobulin as the amyloidogenic protein in dialysis-amyloidosis | |
| DK0486572T3 (da) | Forbedringer i granulocyt-makrofag-kolonistimulerende faktorreceptor og derivater deraf | |
| EP1683866B1 (de) | Deletionsmutanten des IgE-abhängigen Histamin-Releasing-Faktor (HRF) mit der Fähigkeit zur Histaminfreisetzung, HRF-bindende Peptide sowie deren Verwendung | |
| CN111848780A (zh) | 一种IL-36的可溶性受体sIL-36R及其应用 | |
| EP0698666B1 (de) | Modifiziertes Epimorphin | |
| JP3103531B2 (ja) | ヒト尿由来細胞接着糖蛋白質及びその製造方法 | |
| Deyl et al. | Collagen αA and αB chains constitute two separate molecular species | |
| EP0612349B1 (de) | Neues thrombininhibitorisches protein aus raubwanzen | |
| JP3647473B2 (ja) | 個別性をもつ癌細胞を特徴づけるのに有用な、癌の治療的、予防的、診断的薬剤 |